Table 1 Demographics and Clinical Characteristics of the 72 transplant patients enrolled
From: Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients
Characteristics | N (%) |
|---|---|
Sex | |
Male | 44 (61.1%) |
Female | 28 (38.9%) |
Age (μ ± SD) | 9.83 ±3.87 |
Primary disease | |
Congenital Nephrotic Syndrome | 22 (30.6%) |
Hypoplastic/Dysplastic kidney disease | 19 (26.3%) |
Obstructive Uropathy | 10 (13.9%) |
Nephronophthisis | 5 (6.9%) |
Idiopathic FSGS | 4 (5.6%) |
ARPKD | 3 (4.2%) |
Interstitial Nephritis | 3 (4.2%) |
Unknown | 3 (4.2%) |
IgA Nephropathy | 1 (1.4%) |
SLE | 1(1.4%) |
RPGN | 1(1.4%) |
Induction | |
ATG | 21 (29.2%) |
Basiliximab | 51 (70.8%) |
Maintenance immunosuppressants | |
Tac + MMF + Prednisone | 70 (97.2%) |
Tac + Azathoprime+Prednsione | 1 (1.4%) |
Tac + MMF | 1 (1.4%) |
Positive Serology Test Results? | |
Yes, positive anti-SARS-CoV-2 spike protein IgG (Diasorin) + positive anti-SARS-CoV-2 N protein IgG (Abbot) | 8(11.1%) |
No, positive anti-SARS-CoV-2 spike protein IgG (Diasorin) + negative SARS-CoV-2 N protein IgG (Abbot) | 1(1.4%) |
No, negative for both tests | 63(87.5%) |
Total population | 72(100%) |